These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32205868)

  • 1. Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis.
    Goto Y; Ando T; Izumi H; Feng X; Arang N; Gilardi M; Wang Z; Ando K; Gutkind JS
    Oncogene; 2020 May; 39(20):4014-4027. PubMed ID: 32205868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3.
    Asai S; Goto Y; Tanigawa K; Tomioka Y; Kato M; Mizuno K; Sakamoto S; Seki N
    FEBS Lett; 2023 Apr; 597(8):1164-1175. PubMed ID: 36754848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
    Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
    Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
    Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
    Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
    [No Abstract]   [Full Text] [Related]  

  • 5. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
    Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C
    Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH.
    Fu X; Wu H; Li C; Deng G; Chen C
    Mol Cell Biochem; 2024 Sep; 479(9):2415-2427. PubMed ID: 37773303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
    Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
    Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer.
    Mannan Baig A; Khan NA; Effendi V; Rana Z; Ahmad HR; Abbas F
    Anticancer Drugs; 2017 Jan; 28(1):75-87. PubMed ID: 27606721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer.
    Wang J; Wei J; Pu T; Zeng A; Karthikeyan V; Bechtold B; Vo K; Chen J; Lin TP; Chang AP; Corey E; Puhr M; Klocker H; Culig Z; Bland T; Wu BJ
    Cell Rep Med; 2024 Feb; 5(2):101388. PubMed ID: 38262412
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Fararjeh AS; Liu YN
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer.
    Menon R; Deng M; Rüenauver K; Queisser A; Peifer M; Pfeifer M; Offermann A; Boehm D; Vogel W; Scheble V; Fend F; Kristiansen G; Wernert N; Oberbeckmann N; Biskup S; Rubin MA; Adler D; Perner S
    J Pathol; 2013 Dec; 231(4):505-16. PubMed ID: 24114522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the muscarinic M1 and M3 receptor gene expression in the brain stem during pancreatic regeneration and insulin secretion in weanling rats.
    Renuka TR; Ani DV; Paulose CS
    Life Sci; 2004 Sep; 75(19):2269-80. PubMed ID: 15350825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.
    Zheng XM; Zhang P; Liu MH; Chen P; Zhang WB
    Int J Oncol; 2019 Feb; 54(2):443-454. PubMed ID: 30483762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.
    Adler D; Menon R; Braun M; Offermann A; Queisser A; Boehm D; Vogel W; Rüenauver K; Ruiz C; Zellweger T; Svensson M; Andren O; Kristiansen G; Wernert N; Bubendorf L; Kirfel J; Biskup S; Perner S
    Int J Cancer; 2014 Jul; 135(1):19-26. PubMed ID: 24374838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth.
    Li X; Zhuo S; Cho YS; Liu Y; Yang Y; Zhu J; Jiang J
    EMBO J; 2023 Feb; 42(4):e112184. PubMed ID: 36588499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program.
    Parolia A; Venalainen E; Xue H; Mather R; Lin D; Wu R; Pucci P; Rogalski J; Evans JR; Feng F; Collins CC; Wang Y; Crea F
    Mol Oncol; 2019 May; 13(5):1121-1136. PubMed ID: 30776192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.
    Ylitalo EB; Thysell E; Jernberg E; Lundholm M; Crnalic S; Egevad L; Stattin P; Widmark A; Bergh A; Wikström P
    Eur Urol; 2017 May; 71(5):776-787. PubMed ID: 27497761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.